Preoperative High Protein vs Immunodiet in Surgical Cancer Patients
NCT ID: NCT03980704
Last Updated: 2021-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
299 participants
INTERVENTIONAL
2019-04-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Various Diets on Surgical Complications
NCT05069402
Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay
NCT01789073
"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"
NCT04980950
Oral Versus Parenteral Nutrition Support to Improve Protein Balance in Colorectal Surgical Patients
NCT01222208
A Study of Perioperative Oral Nutritional Support for Patients Having Surgery for Colon Cancer, Peri-Nutri
NCT03863236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Protein
Provision of 400 ml per day of high protein oral nutritional supplements
resource protein
Administration of oral high-protein oral supplement
Immuno ONS
Provision of 400 ml per day of immunostimulating oral nutritional supplements
IMPACT
Administration of oral immunostimulating oral supplement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMPACT
Administration of oral immunostimulating oral supplement
resource protein
Administration of oral high-protein oral supplement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written consent
Exclusion Criteria
* known allergy to the drug
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanley Dudrick's Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stanislaw Klek
Head of the Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stanislaw Klek
Role: STUDY_DIRECTOR
Stanley Dudrick's Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanley Dudrick's Memorial Hospital
Skawina, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Imm1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.